The genetic susceptibility to Graves' disease
Authors:
- Terry F. DaviesTDTerry F. Davies
- 1 October 1997
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Endocrinology and Metabolism
- Vol. 11 (3) , 431-450
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Association of HLA‐DQA1*0501 with Graves’ disease in English Caucasian men and womenClinical Endocrinology, 1996
- Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian populationThe Journal of Clinical Endocrinology & Metabolism, 1993
- Lack of Disease Associated Hla-Dq Restriction Fragment Length Polymorphisms in Families with Autoimmune Thyroid DiseaseAutoimmunity, 1993
- HLA-A and DPB1 loci confer susceptibility to Grave's diseaseHuman Immunology, 1992
- Major Histocompatibility Complex (MHC) Factors Predisposing to and Protecting Against Graves' Eye DiseaseAutoimmunity, 1988
- T-cell receptor α chain V region polymorphism linked to primary autoimmune hypothyroidism but not Graves' DiseaseHuman Immunology, 1987
- GENETIC FACTORS IN GRAVES' OPHTHALMOPATHYClinical Endocrinology, 1986
- THE GEOGRAPHICAL DISTRIBUTION OF THYROTOXICOSIS IN ENGLAND ACCORDING TO THE PRESENCE OR ABSENCE OF TSH‐RECEPTOR ANTIBODIESClinical Endocrinology, 1985
- Thyrotoxicosis in Iceland 1980–1982Acta Medica Scandinavica, 1985
- The Epidemiology of Thyrotoxicosis in DenmarkActa Medica Scandinavica, 1980